Official Name: Merck & Co., Inc.
Headquarters: Kenilworth, NJ, United States
CEO: Mr. Robert M. Davis J.D.
USD as of July 1, 2023
Merck & Company, Inc., known as Merck Sharp & Dohme, or MSD, outside the United States and Canada, is one of the largest pharmaceutical companies in the world. Founded in 1891 in the US, and independent since World War I from its parent company, now one of the largest companies in Germany, Merck provides prescription medicines, vaccines, biologic therapies, and animal health products.
|Company||Market Cap (USD)|
|Johnson & Johnson||$412.24 B|
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Pharmaceuticals, generic drugs, over-the-counter drugs, vaccines, diagnostics, contact lenses, animal health (list...)
Founder(s): Theodore Weicker George Merck
Kenneth C. Frazier (Executive Chairman) Robert M. Davis (President and CEO)
Revenue: US$47.994 billion (2020)
Operating income: US$8.791 billion (2020)
Net income: US$7.067 billion (2020)
Total assets: US$89.800 billion (2020)
Total equity: US$29.270 billion (2020)